Publicaciones (23) Publicaciones en las que ha participado algún/a investigador/a

2010

  1. 2009: Anales de Pediatría premiers the impact factor

    Anales de Pediatria, Vol. 73, Núm. 3, pp. 113-114

  2. Association between nitrous oxide and the incidence of postoperative nausea and vomiting in adults: A systematic review and meta-analysis: Review article

    Anaesthesia, Vol. 65, Núm. 4, pp. 379-387

  3. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine

    Vaccine, Vol. 28, Núm. 51, pp. 8065-8072

  4. Complete pathological remission in a patient with hormone-receptor positive and c-erbB-2 expression-negative breast cancer treated with FAC chemotherapy during pregnancy

    Tumori, Vol. 96, Núm. 4, pp. 629-632

  5. Cost-effectiveness analyses of docetaxel versus paclitaxel once weekly in patients with metastatic breast cancer in progression following anthracycline chemotherapy, in Spain

    Clinical and Translational Oncology, Vol. 12, Núm. 10, pp. 692-700

  6. Descenso analgésico o rotación de opiáceos mayores a menores

    DOLOR, Vol. 25, Núm. 2, pp. 103-110

  7. Direct sacral root stimulation: Another possibility in chronic pelvic pain management

    Techniques in Regional Anesthesia and Pain Management, Vol. 14, Núm. 3, pp. 120-127

  8. Doble injerto microvascularizado de peroné para reconstrucción bilateral mandibular por osteorradionecrosis

    Revista Espanola de Cirugia Oral y Maxilofacial, Vol. 32, Núm. 2, pp. 76-80

  9. Editorial: Whither thou goest pain?

    Revista de la Sociedad Espanola del Dolor, Vol. 17, Núm. 4, pp. 187-189

  10. Electric parameters optimization in spinal cord stimulation. Study in conventional nonrechargeable systems

    Neuromodulation, Vol. 13, Núm. 4, pp. 281-287

  11. Estándares de calidad asistencial y catálogo de procedimientos de las unidades de dolor crónico

    Revista de la Sociedad Espanola del Dolor, Vol. 17, Núm. 2, pp. 114-133

  12. Intensive loading dose of trastuzumab achieves higher-than-steady-state serum concentrations and is well tolerated

    Journal of Clinical Oncology, Vol. 28, Núm. 6, pp. 960-966

  13. Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth

    BMC Cancer, Vol. 10

  14. Nanoparticle albumin-bound (nab™)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer

    European Journal of Cancer, Supplement, Vol. 8, Núm. 1, pp. 1-10

  15. Open-label, phase II, multicenter, randomized study of the efficacy and safety of two dose levels of pertuzumab, a human epidermal growth factor receptor 2 dimerization inhibitor, in patients with human epidermal growth factor receptor 2-negative metastatic breast cancer

    Journal of Clinical Oncology, Vol. 28, Núm. 7, pp. 1131-1137

  16. Personalidad y sintomatología frontal en adictos y población no clínica: hacia una neuropsicología de la personalidad

    Adicciones: Revista de socidrogalcohol, Vol. 22, Núm. 3, pp. 233-244

  17. Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine

    Journal of Clinical Oncology, Vol. 28, Núm. 25, pp. 3922-3928

  18. Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy

    Journal of Clinical Oncology, Vol. 28, Núm. 7, pp. 1138-1144

  19. Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer

    Journal of Clinical Oncology, Vol. 28, Núm. 20, pp. 3239-3247

  20. Phase III trials of eribulin mesylate (E7389) in extensively pretreated patients with locally recurrent or metastatic breast cancer

    Clinical Breast Cancer